Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Compare 2024 dividend aristocrats ETF fees to find the lowest cost option. This guide highlights expense ratios and what to look for in a low-cost fund.
27,654 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Traders are watching Ripple’s payments push and regulatory tones as an AI model’s no-guardrails forecast for XRP by 2...
CWB blends income with potential equity upside, but its behavior shifts from bond-like to stock-like in market downtu...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
The EMB ETF offers a ~6% yield on USD EM debt, but a hidden sovereign default risk can erode income and NAV during ma...
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
A solid one-day move in Venture Global stock rose today as analysts lifted price targets and LNG demand expectations ...
New federal disclosures reveal a striking jump in NFT-related income for a high-profile figure, underscoring the grow...
With three years to go before retirement, smart moves in your 401(K) can secure your financial future. This guide off...
South Korea’s KOSPI just suffered a sharp, double-digit drop as rate fears and regional tensions rattled markets. US ...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
Bitcoin holds in the high-$70k range as AI stocks push higher, leaving investors weighing two very different paths. T...